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Objectives and relationship to conference themes
Verrucae are a common, infectious and sometimes pain-
ful problem. The optimal treatment for verrucae is
unclear due to a lack of high quality randomised con-
trolled trials (RCTs). The primary objective of the
EVERT trial is to compare the clinical effectiveness of
two common treatments for verrucae: cryotherapy using
liquid nitrogen delivered by a healthcare professional
versus patient self-treatment with salicylic acid. We aim
to disseminate the trial results amongst podiatrists and
other healthcare professionals who treat verrucae, via
presentation at the SCP Annual Conference 2010 and
publication in a peer-reviewed journal.
Content of presentation
The oral presentation will include background to the
EVERT trial, including previous relevant research and
the need for the current trial, trial design, the results of
the trial and the conclusions drawn from the study.
Relevance/impact of topic
A systematic review conducted by the Cochrane Skin
Group (BMJ, 2002) highlighted the uncertainty with
respect to the optimal treatment of verrucae. Only two
trials were identified which compared salicylic acid and/
or lactic acid with cryotherapy, and they found no dif-
ference in the efficacy between the treatments. However,
both trials were reported as low quality, hence the cur-
rent need for a high quality RCT with a cost effective-
ness analysis to ascertain which is the better approach.
The results of the EVERT trial will be used to inform
clinical practice.
Participant outcomes
The statistical and economic analyses will be completed
by July 2010. The primary outcome is complete clear-
ance of all verrucae at 12 weeks. Secondary outcomes
are time to clearance of verrucae, clearance of verrucae
at six months, pain intensity of the first treatment, use
of painkillers due to verruca treatment, and patient
satisfaction with the treatment. The primary economic
evaluation will be a cost-effectiveness analysis of the
trial treatments.
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